Pharmacology, Toxicology and Pharmaceutical Science
Adenoma
9%
Anticarcinogen
13%
Bevacizumab
13%
Biological Marker
23%
Bortezomib
9%
Breast Cancer
13%
Cancer Model
10%
Caspase
8%
Caspase 8
33%
Chemotherapy
36%
Cisplatin
66%
Clinical Trial
13%
Colon Cancer
31%
Colorectal Cancer
17%
Cytotoxicity
17%
Death Receptor
51%
Death Receptor 4
8%
Disease
17%
DNA Topoisomerase
9%
DNA Topoisomerase (ATP Hydrolysing)
31%
Doxorubicin
27%
Drug Resistance
27%
Epidermal Growth Factor Receptor
11%
Everolimus
20%
Fas Antibody
8%
Fas Ligand
14%
Germ Cell Tumor
12%
Human Papillomavirus
9%
Malignant Neoplasm
57%
Metformin
14%
Mouse
11%
Neoplasm
100%
Non Small Cell Lung Cancer
25%
Non-Steroidal Anti-Inflammatory Drug
15%
Ovary Cancer
56%
Ovary Carcinoma
17%
Ovary Tumor
17%
Overall Survival
12%
Proteasome Inhibitor
10%
Protein P53
65%
Receptor
13%
Small Cell Lung Cancer
41%
Small Interfering RNA
11%
Telomerase
12%
Testis Cancer
31%
Tumor Necrosis Factor
15%
Tumor Necrosis Factor Related Apoptosis Inducing Ligand
77%
Tumor Necrosis Factor Related Apoptosis Inducing Ligand Receptor
25%
Uterine Cervix Cancer
33%
Vasculotropin A
12%
Medicine and Dentistry
Adenoma
28%
Bevacizumab
13%
Biological Marker
19%
Breast Cancer
11%
Cancer Cell
35%
Cancer Therapy
13%
Carcinogenesis
14%
Carcinoma Cell
12%
Caspase 8
25%
Cell Line
20%
Cervical Cancer
21%
Chemoprophylaxis
12%
Cisplatin
32%
Clear Cell Carcinoma
16%
Colon Cancer
11%
Colorectal Cancer
17%
Colorectal Tumor
18%
Death Receptor
33%
Disease
16%
DNA Topoisomerase (ATP Hydrolysing)
16%
Doxorubicin
17%
Drug Resistance
12%
Dysplasia
11%
Epidermal Growth Factor Receptor
14%
Everolimus
16%
Fas Ligand
11%
Glycon
12%
Hereditary Nonpolyposis Colorectal Cancer
13%
Immunohistochemistry
15%
Krukenberg Tumor
19%
Malignant Neoplasm
32%
Molecular Imaging
12%
Neoplasm
85%
Ovarian Cancer
85%
Ovarian Tumor
18%
Polyp
12%
Positron Emission Tomography
14%
Programmed Cell Death
66%
Protein Expression
11%
Protein P53
31%
Radioactive Tracer
13%
Targeted Therapy
12%
Telomerase
24%
Testis Cancer
19%
Tumor Cell
17%
Tumor Necrosis Factor Related Apoptosis Inducing Ligand
55%
Tumor Necrosis Factor Related Apoptosis Inducing Ligand Receptor
27%
Tumor Xenograft
23%
Vasculotropin A
12%
Xenograft
29%
Keyphrases
Apoptosis
6%
Cancer Cells
6%
Cancer Xenograft Model
8%
Caspase-8
7%
Death Receptor
5%
DNA Topoisomerase
8%
Epidermal Growth Factor Receptor
5%
Fas Ligand
5%
Growth Factors
6%
High-grade Serous Ovarian Cancer (HGSOC)
8%
In Cancer
7%
Insulin-like
6%
Melanoma
6%
NVP-AEW541
6%
Obinutuzumab
8%
Ovarian Cancer
7%
Patient-tailored Therapy
5%
Positron Emission Tomography
5%
Recombinant Human
6%
Serous Ovarian Cancer
6%
Therapeutic Potential
11%
Tumor
6%
Tumor Cells
7%
Tumor Growth
5%
Tumor Necrosis Factor-related Apoptosis-inducing Ligand (TRAIL)
9%
Tumor Necrosis Factor-α
5%
Tumor-infiltrating Lymphocytes
6%
